Kewaunee Scientific Corporation Common Stock (KEQU)

FairStock Score: 60/100 — STEADY

Key Financials

Strengths

• Generates $15 million in annual free cash flow (14.5% yield on market cap)
• Solid return on equity of 17.4% above cost of capital

AI Analysis

Kewaunee Scientific Corporation Common Stock is a micro-cap consumer cyclical company valued at $106 million. Revenue stands at $288 million. From a quality standpoint, Kewaunee shows Altman Z-Score of 2.0 in the grey zone and adequate 17% ROE. On valuation, the stock is deeply undervalued on a P/E basis at 9.7x, with a modest 18% margin of safety vs Graham Number. Growth dynamics show revenue growing at 3.3% and profit growth of -48.9%. Our composite FairStock Score of 60/100 reflects above-average fundamentals overall. This combination of reasonable valuation, solid returns, and conservative leverage makes it worth a closer look for value-oriented portfolios.

Bull Case

The market underappreciates Kewaunee's consistent 17% ROE at just 10x earnings—a re-rating toward sector peers could unlock 30-50% upside. With $15 million in annual free cash flow (14.5% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the consumer cyclical space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer